Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $22.9800 (-0.69%) ($22.6000 - $23.2900) on Wed. Nov. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 91 | Latest Price | $22.9800(-0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 24.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) ARKK(45%) IBB(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.09% in a week (0% probabilities). VIXM(-33%) VXX(-26%) UNG(-11%) UUP(-9%) TLT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $22.98(0%) | 10 Day Moving Average | $21.3(7.89%) | 20 Day Moving Average | $17.81(29.03%) | To recent high | -2.3% | To recent low | 83.1% | Market Cap | $1.708b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |